Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP3 | P42574 | 7/20 | 1.00 |
| ▸ | G6PD | P11413 | 4/20 | 1.00 |
| ▸ | PMM2 | O15305 | 5/20 | 0.55 |
| ▸ | MPI | P34949 | 5/20 | 0.55 |
| ▸ | PHOSPHO1 | Q8TCT1 | 5/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | PKM | P14618 | 2/20 | 0.55 |
| ▸ | HPGD | P15428 | 2/20 | 0.55 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.55 |
| ▸ | APOBEC3G | Q9HC16 | 2/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.55 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL16222837 | 0.98 | CASP3 (0.96) | CASP3G6PDPMM2MPIPHOSPHO1 | |
| SCHEMBL16916878 | 0.81 | CASP3 (0.83) | CASP3G6PDFAAHMGLL | |
| SCHEMBL11278746 | 0.77 | CASP3 (0.74) | CASP3G6PDFAAHMGLL | |
| SCHEMBL358740 | 0.75 | FAAH (0.77) | CASP3G6PDFAAHMGLL | |
| SCHEMBL929806 | 0.74 | CASP3 (0.59) | CASP3G6PDPMM2MPIPHOSPHO1 | |
| SCHEMBL27971811 | 0.74 | CASP3 (0.59) | CASP3G6PDPMM2MPIPHOSPHO1 | |
| SCHEMBL10833396 | 0.74 | CASP3 (0.59) | CASP3G6PDPMM2MPIPHOSPHO1 | |
| SCHEMBL26831734 | 0.74 | CASP3 (0.59) | CASP3G6PDPMM2MPIPHOSPHO1 | |
| SCHEMBL18913134 | 0.74 | CASP3 (0.59) | CASP3G6PDPMM2MPIPHOSPHO1 | |
| SCHEMBL2371018 | 0.74 | CASP3 (0.59) | CASP3G6PDPMM2MPIPHOSPHO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1461 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026041525-A1 | AQUEOUS ADHESIVE COMPOSITIONS STABILIZED AGAINST MICROBIAL INFESTATION | THOR GMBH (DE) | 2026-02-26 | — | — | WO | claimed |
| WO-2026041529-A1 | AQUEOUS COMPOSITIONS OF AGRICULTURAL CHEMICALS STABILIZED AGAINST MICROBIAL INFESTATION | THOR GMBH (DE) | 2026-02-26 | — | — | WO | claimed |
| US-20260035753-A1 | METHODS OF DETERMINING BACTERIA AND MANUFACTURING A FIBROUS WEB AND TOOLS AND USES RELATED THERETO | KEMIRA OYJ (FI) | 2026-02-05 | — | — | US | claimed |
| WO-2025125110-A1 | GUANIDINE- AND CARBONATE-CONTAINING COMPOSITIONS | THOR GMBH (DE) | 2025-06-19 | — | — | WO | claimed |
| US-20250172003-A1 | WALL FINISHING SYSTEM | DUROCK ALFACING INTERNATIONAL LIMITED (CA) | 2025-05-29 | — | — | US | claimed |
| CN-119867078-A | Isothiazole compound bactericide and preparation method and application thereof | 四川环科青绿科技有限公司 | 2025-04-25 | — | — | CN | claimed |
| WO-2025082321-A1 | MOLD-PROOF POLYURETHANE COMPOSITION, AND PREPARATION METHOD THEREFOR AND USE THEREOF | SIKA技术股份公司 | 2025-04-24 | — | — | WO | claimed |
| CN-119859233-A | Mildew-proof polyurethane composition, and preparation method and application thereof | SIKA技术股份公司 | 2025-04-22 | — | — | CN | claimed |
| EP-4516862-A1 | AQUEOUS COATING COMPOSITION, COATING OBTAINED FROM THE COATING COMPOSITION, SUBSTRATE CONTAINING THE COATING AND THE USE OF THE AQUEOUS COATING COMPOSITION | DAW SE (DE) | 2025-03-05 | — | — | EP | claimed |
| CN-119504635-A | Method for preparing 2-methyl benzisothiazolin-3-one at room temperature by using NCS | 常州大学 | 2025-02-25 | — | — | CN | claimed |
| US-20040198785-A1 | Microbicidal composition | DDP SPECIALTY ELECTRONIC MATERIALS US 8, LLC | 2004-10-07 | — | — | US | claimed |
| EP-1462003-A1 | Microbiocidal composition | ROHM AND HAAS COMPANY (US) | 2004-09-29 | — | — | EP | claimed |
| US-20040058952-A1 | Urease inhibitors | OTSUKA PHARMACEUTICAL CO., LTD. | 2004-03-25 | — | — | US | claimed |
| EP-1315419-A1 | SYNERGETIC BIOCIDAL COMPOSITION COMPRISING 2-METHYLISOTHIAZOLINE-3-ON | THOR GmbH (DE) | 2003-06-04 | — | — | EP | claimed |
| US-20030060482-A1 | Urease inhibitors | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2003-03-27 | — | — | US | claimed |
| EP-1262181-A1 | UREASE INHIBITORS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2002-12-04 | — | — | EP | claimed |
| WO-2002017716-A1 | SYNERGETIC BIOCIDAL COMPOSITION COMPRISING 2-METHYLISOTHIAZOLINE-3-ON | THOR GMBH (DE) | 2002-03-07 | — | — | WO | claimed |
| EP-0755392-A4 | ALPHA1C ADRENERGIC RECEPTOR ANTAGONISTS | MERCK & CO INC (US) | 1997-05-02 | — | — | EP | claimed |
| EP-0755392-A1 | ALPHA1C ADRENERGIC RECEPTOR ANTAGONISTS | MERCK & CO. INC. (US) | 1997-01-29 | — | — | EP | claimed |
| WO-1995028397-A1 | ALPHA1C ADRENERGIC RECEPTOR ANTAGONISTS | MERCK & CO., INC. (US) | 1995-10-26 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030060482-A1 | Urease inhibitors | PGC, SLC14A1, USP1 | CASP3 2704/4885G6PD 124/4885PMM2 3405/4885 |
| US-20040198785-A1 | Microbicidal composition | TLR2, FABP2, TLR1 | CASP3 1223/4885G6PD 1809/4885PMM2 3941/4885 |
| US-20260035753-A1 | METHODS OF DETERMINING BACTERIA AND MANUFACTURING A FIBROUS WEB AND TOOLS AND USES RELATED THERETO | POLL, UROD, RNGTT | CASP3 3259/4885G6PD 1010/4885PMM2 187/4885 |
| US-20040058952-A1 | Urease inhibitors | PGC, SLC14A1, USP1 | CASP3 2704/4885G6PD 124/4885PMM2 3405/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.